content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001350778</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001368514</issuerCik>
        <issuerName>ADMA BIOLOGICS, INC.</issuerName>
        <secFileNumber>001-36728</secFileNumber>
        <issuerAddress>
          <com:street1>C/O ADMA BIOLOGICS, INC.</com:street1>
          <com:street2>465 STATE ROUTE 17</com:street2>
          <com:city>RAMSEY</com:city>
          <com:stateOrCountry>NJ</com:stateOrCountry>
          <com:zipCode>07446</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>(201) 478-5552</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Aisling Capital II LP</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Affiliate</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Merrill Lynch</name>
          <address>
            <com:street1>One Bryant Park</com:street1>
            <com:street2>28th Floor</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10036</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>1500000</noOfUnitsSold>
        <aggregateMarketValue>9330000.00</aggregateMarketValue>
        <noOfUnitsOutstanding>228220236</noOfUnitsOutstanding>
        <approxSaleDate>03/13/2024</approxSaleDate>
        <securitiesExchangeName>NASDAQ</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>07/17/2007</acquiredDate>
        <natureOfAcquisitionTransaction>Private Placement</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>1500000</amountOfSecuritiesAcquired>
        <paymentDate>07/17/2007</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <noticeSignature>
        <noticeDate>03/13/2024</noticeDate>
        <signature>Robert Wenzel</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2815}]
text: 144
  0001350778
  XXXXXXXX
  LIVE
  0001368514
  ADMA BIOLOGICS, INC.
  001-36728
  C/O ADMA BIOLOGICS, INC.
  465 STATE ROUTE 17
  RAMSEY
  NJ
  07446
  (201) 478-5552
  Aisling Capital II LP
  Affiliate
  Common Stock
  Merrill Lynch
  One Bryant Park
  28th Floor
  New York
  NY
  10036
  1500000
  9330000.00
  228220236
  03/13/2024
  NASDAQ
  Common Stock
  07/17/2007
  Private Placement
  Issuer
  N
  1500000
  07/17/2007
  Cash
  Y
  03/13/2024
  Robert Wenzel